Covista Inc. (CVSA) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Covista Inc. (CVSA) advanced +1.79% to $128.76 as options desks priced 57% call premium vs. 43% put protection around the $126 max-pain magnet. Solid 57% profit margin (15% return on capital), mixed timing at 18x P/E—hold if owned, no rush to chase.
Covista (CVSA) just packed several events into one earnings day, reporting first quarter results, lifting 2027 revenue guidance, announcing a CFO retirement plan, and updating progress on its ongoing share repurchase pro
Covista has delivered a powerful share price run in recent years, which now puts a spotlight on whether the current market value lines up with what its earnings can support. With the stock coming off fresh news on its gr
Covista reported first quarter fiscal 2027 results with US$511.53 million in sales, higher net income, and raised full year 2027 revenue guidance to a range of US$2,060 million to US$2,095 million after solid enrollment
Revenue hit $511.5 million with enrollment climbing for 13th straight quarter.
Covista (CVSA) maintains a Buy rating as recent results reinforce confidence in business direction and profitability improvements, especially at Walden.
Covista (CVSA) Q1 2027 revenue and EPS beat estimates; the healthcare educator raised FY guidance and shares rose modestly after hours.
Covista (CVSA) delivered earnings and revenue surprises of +15.26% and +3.93%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
CHICAGO (AP) — CHICAGO (AP) — Covista Inc. (CVSA) on Thursday reported profit of $67.
Vocational education company Covista (NYSE:CVSA) reported calendar Q3 2026 (fiscal Q1 2027) results beating Wall Street’s revenue expectations, with revenue up 10.7% year on year to $511.5 million. The company expects th
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +12.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CVSA today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CVSA. Explore sector supply chains on /butterfly.
Why CVSA Stock advanced +1.79% Today — RQD Quant Desk Flash. Solid 57% profit margin (15% return on capital), mixed timing at 18x P/E—hold if owned, no rush to chase.